Frequently asked questions

*

For more information on the terms and conditions to join the Trials@Home consortium, please contact:

Philippe Bordes
philippe.bordes@sanofi.com

or

Nathalie Vigot
trialsathome@umcutrecht.nl

They will happily explain you the procedure.

The aim of the glossary is to establish a common language and to aid understanding of key terms that will feature in project outputs. The glossary itself, presented in the document, may be updated during the Trials@Home project so that important new terms can be added, obsolete terms removed, or existing terms updated to significant new insights. This approach has been chosen to reflect the fast-changing remote decentralised clinical trial landscape.

Click here to consult the Trials@Home Glossary

April 2020 – Identifying existing RCDT solutions

In this current stage we are exploring and mapping existing RDCT technologies across-the-board in any stage of the RCT.

To support our research we provide the opportunity for companies to submit their technologies through a Request for Information.

Please click here to see if your technology fits one of the categories and submit your information.